Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PHARMACEUTICALS

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

CYCLOBENZAPRINE HYDROCHLORIDECRS (20 MG)

CYCLOBENZAPRINE HYDROCHLORIDECRS (20 MG)

ND

DISCOVER
Carbidopa Impurity G

Carbidopa Impurity G

NA

DISCOVER
CYCLOHEXA-1,4-DIENYLGLYCINE CRS (15 MG)

CYCLOHEXA-1,4-DIENYLGLYCINE CRS (15 MG)

26774-88-9

DISCOVER
Citalopram desfluoro oxalate (rac)

Citalopram desfluoro oxalate (rac)

1093072-86-6

DISCOVER
CYCLOPENTOLATE HYDROCHLORIDE CRS (80 MG)

CYCLOPENTOLATE HYDROCHLORIDE CRS (80 MG)

5870-29-1

DISCOVER
CYCLOPHOSPHAMIDE CRS (50 MG)

CYCLOPHOSPHAMIDE CRS (50 MG)

6055-19-2

DISCOVER
Carnitine DL HCl

Carnitine DL HCl

461-05-2

DISCOVER
Cyproheptadine HCl 1/2 H2O

Cyproheptadine HCl 1/2 H2O

41354-29-4

DISCOVER
CYPROHEPTADINE HYDROCHLORIDE CRS (15 MG)

CYPROHEPTADINE HYDROCHLORIDE CRS (15 MG)

41354-29-4

DISCOVER
CYPROTERONE ACETATE CRS (30 MG)

CYPROTERONE ACETATE CRS (30 MG)

427-51-0

DISCOVER
Choline citrate dihydrogen

Choline citrate dihydrogen

77-91-8

DISCOVER
CYSTEINE HYDROCHLORIDE MONOHYDRATE CRS (100 MG)

CYSTEINE HYDROCHLORIDE MONOHYDRATE CRS (100 MG)

06/04/7048

DISCOVER